Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-10-17 Sale | 2023-03-09 4:06 pm | bluebird bio Inc. | BLUE | Leiderman Elisabeth Director | 1,004 | $6.4643 | $6,490 | 11,466 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-11-06 Option Award | 2024-11-08 4:08 pm | N/A 2034-11-06 | bluebird bio Inc. | BLUE | Leiderman Elisabeth Director | 74,750 | $0 | 97,006 (Direct) | View |
2023-06-16 Option Award | 2023-06-20 4:30 pm | N/A 2033-06-16 | bluebird bio Inc. | BLUE | Leiderman Elisabeth Director | 32,390 | $0 | 43,856 (Direct) | View |
2022-06-22 Option Award | 2022-06-23 6:08 pm | N/A 2032-06-22 | bluebird bio Inc. | BLUE | Leiderman Elisabeth Director | 8,109 | $0 | 17,470 (Direct) | View |
2022-02-25 Option Award | 2022-02-28 4:37 pm | N/A 2032-02-24 | Decibel Therapeutics Inc. | DBTX | Leiderman Elisabeth Chief Financial Officer | 52,500 | $0 | 52,500 (Direct) | View |
2021-11-11 Other | 2021-11-16 06:26 am | N/A N/A | bluebird bio Inc. | BLUE | Leiderman Elisabeth Director | 9,361 | $0 | 33,779 (Direct) | View |
2021-11-11 Disposition | 2021-11-16 06:26 am | N/A 2031-10-15 | bluebird bio Inc. | BLUE | Leiderman Elisabeth Director | 15,057 | $0 | 33,779 (Direct) | View |
2021-10-15 Option Award | 2021-10-19 8:00 pm | N/A 2031-10-15 | bluebird bio Inc. | BLUE | Leiderman Elisabeth Director | 12,163 | $0 | 12,163 (Direct) | View |
Ownership | 2021-02-11 9:07 pm | N/A 2030-12-07 | Decibel Therapeutics Inc. | DBTX | Leiderman Elisabeth See Remarks | 0 | $0 | 207,312 (Direct) | View |